Onsi Douglas E Insider Trades

Insider Trading History

Track insider trading activity for Onsi Douglas E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.&sec.
Holding Value $81.7k 106,146 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.3k 32,500 shares
$0.32
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.&sec.
Holding Value $0 0 shares
Last Trade
Mar 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.3k 32,500 shares
$0.32
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.&sec.
Holding Value $0 0 shares
Last Trade
Nov 13, 2024 Sale (In The Money)Reported as In The Money on SEC Form 4.
$6.02k 2,136 shares
$2.82
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.&sec.
Holding Value $522k 678,456 shares
Last Trade
Nov 13, 2024 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$6.02k 2,136 shares
$2.82
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $131k 170,000 shares
Last Trade
Oct 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 170,000 shares
$2.45
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $131k 170,000 shares
Last Trade
Jan 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$456k 170,000 shares
$2.68
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $56.7k 73,646 shares
Last Trade
Jan 26, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.3k 7,500 shares
$2.44
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.3k 7,500 shares
$2.44
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $108k 140,000 shares
Last Trade
Aug 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 140,000 shares
$2.21
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $577k 750,000 shares
Last Trade
Mar 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.5M 750,000 shares
$34.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $0 0 shares
Last Trade
Mar 17, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$24.1M 660,606 shares
$36.42
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $509k 661,466 shares
Last Trade
Mar 17, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$24.1M 660,606 shares
$36.42
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $154k 200,000 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.6M 200,000 shares
$143.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner, Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $250k 325,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.1M 325,000 shares
$194.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner, Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $23.1k 30,000 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.86M 30,000 shares
$162.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $0 0 shares
Last Trade
Feb 09, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$151M 571,428 shares
$265.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $8.88k 11,544 shares
Last Trade
Feb 09, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$3.06M 11,544 shares
$265.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner, Ceo,cfo,pres.,gc,treas.,&sec.
Holding Value $135k 175,000 shares
Last Trade
Jan 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45M 175,000 shares
$257.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
10% owner, Ceo, Pres.,gc, Treas., & Sec.
Holding Value $57.7k 75,000 shares
Last Trade
Aug 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.7M 75,000 shares
$196.50
$0.77
TetraLogic Pharmaceuticals
TetraLogic Pharmaceuticals TLOG
Director
Holding Value $0 10,000 shares
Last Trade
Jan 28, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up